These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24684735)

  • 1. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
    Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
    Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma.
    Zheng L; Chen K; Zhu L; Su D; Cheng G
    Onco Targets Ther; 2017; 10():5719-5726. PubMed ID: 29238204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells].
    Zhang K; Wang W; Wu K; Ding C; Zhu J; DU Y; Guan Z; Wang X; Fan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):668-676. PubMed ID: 28502307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
    Patschan O; Shariat SF; Chade DC; Karakiewicz PI; Ashfaq R; Lotan Y; Hotakainen K; Stenman UH; Bjartell A
    World J Urol; 2012 Dec; 30(6):785-94. PubMed ID: 21739120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.
    Fan X; Wang Y; Fan J; Chen R
    J Cell Biochem; 2019 Jun; 120(6):10643-10651. PubMed ID: 30672020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition.
    Tseng WC; Chuang CW; Yang MH; Pan CC; Tarng DC
    Urol Oncol; 2016 Nov; 34(11):485.e15-485.e24. PubMed ID: 27519276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?
    Manoharan M; Katkoori D; Kishore TA; Jorda M; Luongo T; Soloway MS
    World J Urol; 2010 Apr; 28(2):233-7. PubMed ID: 19597735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder.
    Kim PH; Cha EK; Sfakianos JP; Iyer G; Zabor EC; Scott SN; Ostrovnaya I; Ramirez R; Sun A; Shah R; Yee AM; Reuter VE; Bajorin DF; Rosenberg JE; Schultz N; Berger MF; Al-Ahmadie HA; Solit DB; Bochner BH
    Eur Urol; 2015 Feb; 67(2):198-201. PubMed ID: 25092538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
    Martini T; Heinkele J; Mayr R; Weis CA; Wezel F; Wahby S; Eckstein M; Schnöller T; Breyer J; Wirtz R; Ritter M; Bolenz C; Erben P
    Urol Oncol; 2018 Dec; 36(12):530.e19-530.e27. PubMed ID: 30446441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
    Li Z; Wang KE; Zhou XL; Zhou J; Ye CH
    Med Sci Monit; 2018 Jan; 24():438-447. PubMed ID: 29358570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
    Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
    Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DAB2IP-knocking down resulted in radio-resistance of breast cancer cells is associated with increased hypoxia and vasculogenic mimicry formation.
    Zhang X; Wang Q; Zhang R; Kong Z
    Int J Radiat Biol; 2023; 99(10):1595-1606. PubMed ID: 36947637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
    Liu W; Qi L; Lv H; Zu X; Chen M; Wang J; Liu L; Zeng F; Li Y
    BMC Cancer; 2015 Mar; 15():92. PubMed ID: 25884322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.